NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients

BACKGROUND: In Peru, 32,970 people were diagnosed with tuberculosis (TB) in 2019. Although TB treatment is effective, 3.4%–13% is associated with significant adverse drug reactions (ADR), considering drug‐induced liver injury (DILI) as the most prevalent. Among the first‐line anti‐TB drugs, isoniazi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaramillo‐Valverde, Luis, Levano, Kelly S., Tarazona, David D., Capristano, Silvia, Zegarra‐Chapoñan, Roberto, Sanchez, Cesar, Yufra‐Picardo, Velia M., Tarazona‐Santos, Eduardo, Ugarte‐Gil, Cesar, Guio, Heinner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356556/
https://www.ncbi.nlm.nih.gov/pubmed/35751408
http://dx.doi.org/10.1002/mgg3.1987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356556/
https://www.ncbi.nlm.nih.gov/pubmed/35751408
http://dx.doi.org/10.1002/mgg3.1987

Ejemplares similares